KZKai Zhang

Kai Zhang

*This is an algorithmically generated author record based on publicly available information.

Kai Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bing-Dong Sui

    State key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi International Joint Research Center for Oral Diseases, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi’an, China

    1 shared publication
  • Chen-Xi Zheng

    State key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi International Joint Research Center for Oral Diseases, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi’an, China

    1 shared publication
  • Lufan Yang

    1 shared publication
  • Sha Zhang

    College of Life Science, Northwest University, Xi'an, Shaanxi 710069, China

    1 shared publication
  • Shengfeng Bai

    1 shared publication
  • Siyu Lan

    State Key Laboratory of Military Stomatology and National Clinical Research Center for Oral Diseases and Shaanxi Clinical Research Center for Oral Diseases, Department of Orthodontics, School of Stomatology, The Fourth Military Medical University, Xian, China

    1 shared publication

Latest Publications

  • Open Access

    Mesenchymal Stem Cell-Derived Extracellular Vesicles in Therapeutic Use

    by Yu Fu, Lufan Yang, Siyu Lan, Sha Zhang, Kai Zhang, Shengfeng Bai, Wen Qin, Chenxi Zheng, Bingdong Sui

    Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapeutic strategy in regenerative medicine and immunomodulation. These nanosized vesicles, carrying bioactive molecules like miRNAs, proteins, and lipids, exhibit dual capabilities in regulating immune responses and promoting tissue repair. MSC-EVs promote tissue regeneration, including revascularization, skeletal and dental tissue repair, wound healing, hepatic and renal regeneration, and neural repair. Simultaneously, their immunomodulatory properties-suppressing excessive inflammation and regulating immune cell activity, make them promising interventions for autoimmune, neurodegenerative, and inflammatory conditions. By integrating tissue repair with immune regulation, MSC-EVs represent a transformative paradigm in precision therapeutics, meriting accelerated clinical exploration.